Mahima Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 05-11-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 05-11-2024
- Satisfied Charges ₹ 8.90 M
as on 05-11-2024
About Mahima Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹8.90 M, as per Ministry of Corporate Affairs (MCA) records.
Neelam Verma and Megha Sharma serve as directors at the Company.
- CIN/LLPIN
U51909DL2022PTC395636
- Company No.
395636
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mahima Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neelam Verma  | Director | 28-Mar-2022 | Current |
| Megha Sharma | Director | 10-Oct-2022 | Current |
Financial Performance of Mahima Biotech.
Mahima Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mahima Biotech?
Unlock access to Mahima Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Friedrich Organic Chemicals India Private LimitedActive 4 years 8 monthsNeelam Verma and Megha Sharma are mutual person
Maya Energies Private LimitedActive 5 years 10 monthsNeelam Verma and Megha Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 01 Feb 2024 | ₹2.00 Cr | Open |
Others Creation Date: 18 May 2022 | ₹8.90 M | Satisfied |
How Many Employees Work at Mahima Biotech?
Mahima Biotech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahima Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahima Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
